178 related articles for article (PubMed ID: 37928607)
1. Bedaquiline Resistance and Molecular Characterization of Rifampicin-Resistant
Tong E; Zhou Y; Liu Z; Zhu Y; Zhang M; Wu K; Pan J; Jiang J
Infect Drug Resist; 2023; 16():6951-6963. PubMed ID: 37928607
[TBL] [Abstract][Full Text] [Related]
2. Bedaquiline resistance pattern in clofazimine-resistant clinical isolates of tuberculosis patients.
Shang Y; Chen S; Shi W; Nie W; Jing W; Huo F; Xue Y; Dong L; Jiang G; Huang H; Chu N
J Glob Antimicrob Resist; 2023 Jun; 33():294-300. PubMed ID: 37142094
[TBL] [Abstract][Full Text] [Related]
3. Variants associated with Bedaquiline (BDQ) resistance identified in Rv0678 and efflux pump genes in Mycobacterium tuberculosis isolates from BDQ naïve TB patients in Pakistan.
Saeed DK; Shakoor S; Razzak SA; Hasan Z; Sabzwari SF; Azizullah Z; Kanji A; Nasir A; Shafiq S; Ghanchi NK; Hasan R
BMC Microbiol; 2022 Feb; 22(1):62. PubMed ID: 35209842
[TBL] [Abstract][Full Text] [Related]
4. Primary Bedaquiline Resistance Among Cases of Drug-Resistant Tuberculosis in Taiwan.
Wu SH; Chan HH; Hsiao HC; Jou R
Front Microbiol; 2021; 12():754249. PubMed ID: 34745058
[TBL] [Abstract][Full Text] [Related]
5. Bedaquiline- and clofazimine- selected Mycobacterium tuberculosis mutants: further insights on resistance driven largely by Rv0678.
Snobre J; Villellas MC; Coeck N; Mulders W; Tzfadia O; de Jong BC; Andries K; Rigouts L
Sci Rep; 2023 Jun; 13(1):10444. PubMed ID: 37369740
[TBL] [Abstract][Full Text] [Related]
6. Whole Genome Sequencing Identifies Novel Mutations Associated With Bedaquiline Resistance in
Guo Q; Bi J; Lin Q; Ye T; Wang Z; Wang Z; Liu L; Zhang G
Front Cell Infect Microbiol; 2022; 12():807095. PubMed ID: 35694543
[TBL] [Abstract][Full Text] [Related]
7. Molecular characteristics and in vitro susceptibility to bedaquiline of Mycobacterium tuberculosis isolates circulating in Shaanxi, China.
Yang J; Pang Y; Zhang T; Xian X; Li Y; Wang R; Wang P; Zhang M; Wang J
Int J Infect Dis; 2020 Oct; 99():163-170. PubMed ID: 32738481
[TBL] [Abstract][Full Text] [Related]
8. Genotype-Phenotype Characterization of Serial Mycobacterium tuberculosis Isolates in Bedaquiline-Resistant Tuberculosis.
Brown TS; Tang L; Omar SV; Joseph L; Meintjes G; Maartens G; Wasserman S; Shah NS; Farhat MR; Gandhi NR; Ismail N; Brust JCM; Mathema B
Clin Infect Dis; 2024 Feb; 78(2):269-276. PubMed ID: 37874928
[TBL] [Abstract][Full Text] [Related]
9. Investigation of bedaquiline resistance and genetic mutations in multi-drug resistant Mycobacterium tuberculosis clinical isolates in Chongqing, China.
Hu Y; Fan J; Zhu D; Liu W; Li F; Li T; Zheng H
Ann Clin Microbiol Antimicrob; 2023 Feb; 22(1):19. PubMed ID: 36855179
[TBL] [Abstract][Full Text] [Related]
10. Genetic variants and their association with phenotypic resistance to bedaquiline in
Ismail N; Rivière E; Limberis J; Huo S; Metcalfe JZ; Warren RM; Van Rie A
Lancet Microbe; 2021 Nov; 2(11):e604-e616. PubMed ID: 34796339
[TBL] [Abstract][Full Text] [Related]
11. Delamanid and bedaquiline resistance patterns in
Akbari Aghababa A; Nasiri MJ; Pakzad P; Mirsamadi ES
New Microbes New Infect; 2024; 60-61():101437. PubMed ID: 38873345
[TBL] [Abstract][Full Text] [Related]
12.
Degiacomi G; Sammartino JC; Sinigiani V; Marra P; Urbani A; Pasca MR
Front Microbiol; 2020; 11():559469. PubMed ID: 33042066
[TBL] [Abstract][Full Text] [Related]
13. Population-level emergence of bedaquiline and clofazimine resistance-associated variants among patients with drug-resistant tuberculosis in southern Africa: a phenotypic and phylogenetic analysis.
Nimmo C; Millard J; van Dorp L; Brien K; Moodley S; Wolf A; Grant AD; Padayatchi N; Pym AS; Balloux F; O'Donnell M
Lancet Microbe; 2020 Aug; 1(4):e165-e174. PubMed ID: 32803174
[TBL] [Abstract][Full Text] [Related]
14. Acquisition of clofazimine resistance following bedaquiline treatment for multidrug-resistant tuberculosis.
Liu Y; Gao J; Du J; Shu W; Wang L; Wang Y; Xue Z; Li L; Xu S; Pang Y
Int J Infect Dis; 2021 Jan; 102():392-396. PubMed ID: 33130209
[TBL] [Abstract][Full Text] [Related]
15. Reduced Susceptibility of Mycobacterium tuberculosis to Bedaquiline During Antituberculosis Treatment and Its Correlation With Clinical Outcomes in China.
Liu Y; Gao M; Du J; Wang L; Gao J; Shu W; Wang Y; Xue Z; Li L; Pang Y
Clin Infect Dis; 2021 Nov; 73(9):e3391-e3397. PubMed ID: 32667984
[TBL] [Abstract][Full Text] [Related]
16. Bedquiline Resistance Mutations: Correlations with Drug Exposures and Impact on the Proteome in M. tuberculosis.
Xu J; Li D; Shi J; Wang B; Ge F; Guo Z; Mu X; Nuermberger E; Lu Y
Antimicrob Agents Chemother; 2023 Jul; 67(7):e0153222. PubMed ID: 37255473
[TBL] [Abstract][Full Text] [Related]
17. The importance of heteroresistance and efflux pumps in bedaquiline-resistant Mycobacterium tuberculosis isolates from Iran.
Madadi-Goli N; Ahmadi K; Kamakoli MK; Azizi M; Khanipour S; Dizaji SP; Nasehi M; Siadat SD; Fateh A; Vaziri F
Ann Clin Microbiol Antimicrob; 2024 Apr; 23(1):36. PubMed ID: 38664815
[TBL] [Abstract][Full Text] [Related]
18. [Study on the resistance of rifampicin-resistant Mycobacterium tuberculosis to anti-tuberculosis drugs in group A].
Dai XW; Li CY; Wang NH; Chen SS; Tian LL; Zhao YF; Tao LY; Yang XY; Ding BC; He XX
Zhonghua Jie He He Hu Xi Za Zhi; 2023 Nov; 46(11):1110-1117. PubMed ID: 37914422
[No Abstract] [Full Text] [Related]
19. Bedaquiline resistant Mycobacterium tuberculosis clinical isolates with and without rv0678 mutations have similar growth patterns under varying BDQ drug pressure.
Saeed DK; Ashraf J; Hasan Z; Shakoor S; Kanji A; Hasan R
Tuberculosis (Edinb); 2022 Dec; 137():102266. PubMed ID: 36195000
[TBL] [Abstract][Full Text] [Related]
20. Molecular mechanisms of resistance and treatment efficacy of clofazimine and bedaquiline against
Islam MM; Alam MS; Liu Z; Khatun MS; Yusuf B; Hameed HMA; Tian X; Chhotaray C; Basnet R; Abraha H; Zhang X; Khan SA; Fang C; Li C; Hasan S; Tan S; Zhong N; Hu J; Zhang T
Front Med (Lausanne); 2023; 10():1304857. PubMed ID: 38274444
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
